Aptamers for prep measurement - EO: 14398
Active Purchase Order Awarded Last action
- Contract number
- 75D30126P21205
- Awardee
-
University Of North Carolina At Chapel Hill UEI D3LHU66KBLD5 Part of University Of North Carolina System Office
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $330,000
Award facts
- Opportunity
-
- Notice of Intent to issue a Sole Source Award to generate and optimize high-affinity nucleic acid aptamers capable of semi-quantitative detection of TFV-DP and/or TFV for use in both plate-based assays and POC platforms. Pre-Solicitation · 75D30126R73457 · Posted May 18, 2026
- Contract value 100% obligated
- $330,000.00 Current and potential, with all options
- Completion date 6% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30329, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Centers for Disease Control and Prevention awarded a $330,000 firm-fixed-price purchase order to the University of North Carolina at Chapel Hill on September 4, 2026, for development and optimization of nucleic acid aptamers for tenofovir (TFV-DP and TFV) detection in plate-based assays and point-of-care platforms.
This is a sole-source procurement under NAICS 541715 (Medical Research and Development Laboratories or Services) and PSC AJ12 (General Science and Technology R&D Services). UNC was selected as the only reasonably available source due to its role as co-inventor of the FTC aptamer used in prior antiretroviral-detection research and its established methodologies compatible with CDC's current assay development. The pre-solicitation notice, posted May 18, 2026, with a June 2 quotation deadline, noted that switching vendors would require restart of the entire optimization process and incompatibility with the existing emtricitabine-detecting aptamer.
Performance occurs in Atlanta, Georgia through September 30, 2028. Executive Order 14398 applies to this award.
Quick answers
Who was awarded contract 75D30126P21205?
75D30126P21205 was awarded to University Of North Carolina At Chapel Hill by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 4, 2026.
How much is contract 75D30126P21205 worth?
The government has obligated $330,000 on 75D30126P21205.
Was contract 75D30126P21205 competed?
The extent of competition for 75D30126P21205 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award